Insurance industry analysts are anxiously waiting for CVS Health to report its Q4 2018 financial results. It'll be the first quarter since the pharmacy behemoth closed its $70 billion deal to acquire health insurer Aetna in November.
DaVita reported net income of $159 million in 2018, down from $664 million in 2017. The company's CEO assured the audience on a call Thursday that the sale of DaVita Medical Group to UnitedHealth Group will close soon.
Baylor Scott & White is the latest health system whose non-operating results took a hit on weak investment returns. Despite that, its revenue and operating margin inched up.
Real estate investment trust Welltower saw its profit jump 53% year-over-year in 2018, and the company's leaders say much of its growth is being driven by partnerships with big-name health systems like Providence St. Joseph Health, Johns Hopkins and Ascension.
Molina Healthcare swung to a profit in the fourth quarter and full year 2018, after taking steps to slash medical and administrative costs.
Kaiser Permanente's non-operating income dropped 71% in 2018 as the Oakland, Calif.-based not-for-profit health system dealt with volatile investment markets.
Louisville, Ky.-based health insurer Humana recorded higher revenue in the fourth quarter of 2018, as it brought in more premium revenue from Medicare Advantage plans.
Despite near-record bookings in the fourth quarter of 2018, Cerner Corp. missed its revenue expectations and recorded a sharp drop in operating earnings.
WellCare Health Plans CEO Ken Burdick called 2018 a "very good year" for the insurer. That's thanks in part to its $2.5 billion acquisition of Meridian Health Plan and related 44% increase in Medicaid customers.
Premier reported strong growth in its performance services segment in the second quarter of its fiscal 2019, while its much larger supply chain services segment grew only 1% year-over-year.
Centene Corp.'s Affordable Care Act exchange membership reached nearly 1.5 million last year, helping boost the health insurer's revenue during the fourth-quarter and full-year 2018.
Cigna's CEO waved off concerns that HHS' proposal to curtail PBM drug rebates could disrupt its business. Cigna reported higher revenue but lower profit in the fourth quarter of 2018 after bringing Express Scripts into the fold.